CryoLife-O'Brien stentless valve: 10-year results of 402 implants.

Background: This truly stentless porcine valve is composite, without Dacron, and implanted supra-annularly. Ten-year analysis with magnetic resonance imaging is presented.

Methods: From 1992 to 2002, 402 patients (mean 73.

BioGlue Surgical Adhesive--an appraisal of its indications in cardiac surgery.

Background: The recent emergence of BioGlue Surgical Adhesive has widened the field of surgical adhesives for the cardiac surgeon. We believe the present series, in a wider spectrum of cardiac conditions, is the first larger scale evaluation of the use of this new adhesive.

Methods: BioGlue was used in 115 consecutive patients (90 male and 25 female, age range 5 days to 87 years) from September 9, 1998 to March 12, 2001.

Influence of patient age and implantation technique on the probability of re-replacement of the homograft aortic valve.

Background And Aim Of The Study: Results of valve rereplacement (reoperation) in 898 patients undergoing aortic valve replacement with cryopreserved homograft valves between 1975 and 1998 are reported. The study aim was to provide estimates of unconditional probability of valve reoperation and cumulative incidence function (actual risk) of reoperation.

Methods: Valves were implanted by subcoronary insertion (n = 500), inclusion cylinder (n = 46), and aortic root replacement (n = 352).

Primary aortic valve replacement with cryopreserved aortic allograft: an echocardiographic follow-up study of 570 patients.

Background: Despite the many advantages of an aortic allograft valve (AAV) over a prosthetic aortic valve, its durability is suboptimal. The aims of the present study were to document characteristic features of AAV dysfunction and to investigate factors influencing the development of such dysfunction.

Methods And Results: A group of 570 patients (mean age, 48+/-16 years) with a cryopreserved AAV underwent a follow-up echocardiographic study (mean time after surgery, 6.